Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Cmp Dev Llc Drug Patent Portfolio

Cmp Dev Llc owns 6 orange book drugs protected by 27 US patents with Potassium Phosphates having the least patent protection, holding only 1 patent. And Carospir with maximum patent protection, holding 8 patents. Given below is the list of Cmp Dev Llc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11253474 Pharmaceutical solution of amlodipine 24 Feb, 2041
Active
US11458095 Pharmaceutical solution of amlodipine 24 Feb, 2041
Active
US11723866 Pharmaceutical solution of amlodipine 24 Feb, 2041
Active
US12005141 Pharmaceutical solution of amlodipine 24 Feb, 2041
Active
US12226528 Pharmaceutical solution of amlodipine 24 Feb, 2041
Active
US10632150 Potassium phosphates composition for injection 19 Apr, 2039
Active
US11337979 Liquid oral formulations for sildenafil 24 Dec, 2038
Active
US11464778 Liquid oral formulations for sildenafil 24 Dec, 2038
Active
US11759468 Liquid oral formulations for sildenafil 24 Dec, 2038
Active
US12005062 Liquid oral formulations for sildenafil 24 Dec, 2038
Active
US12186321 Liquid oral formulations for sildenafil 24 Dec, 2038
Active
US11382917 Liquid oral formulations for tadalafil 24 Dec, 2038
Active
US11666576 Liquid oral formulations for tadalafil 24 Dec, 2038
Active
US11975006 Liquid oral formulations for tadalafil 24 Dec, 2038
Active
US12186322 Liquid oral formulations for tadalafil 24 Dec, 2038
Active
US11369567 Aqueous suspension suitable for oral administration 07 Jun, 2037
Active
US11654106 Aqueous suspension suitable for oral administration 07 Jun, 2037
Active
US11925704 Aqueous suspension suitable for oral administration 07 Jun, 2037
Active
US12168069 Aqueous suspension suitable for oral administration 07 Jun, 2037
Active
US10493083 Spironolactone aqueous compositions 28 Oct, 2036
Active
US10624906 Spironolactone aqueous compositions 28 Oct, 2036
Active
US10660907 Spironolactone aqueous compositions 28 Oct, 2036
Active
US10888570 Spironolactone aqueous compositions 28 Oct, 2036
Active
US11389461 Spironolactone aqueous compositions 28 Oct, 2036
Active
US11395828 Spironolactone aqueous compositions 28 Oct, 2036
Active
US11491166 Spironolactone aqueous compositions 28 Oct, 2036
Active
US9757394 Spironolactone aqueous formulations 28 Oct, 2036
Active


Given below is the list of recent legal activities going on the following drug patents of Cmp Dev Llc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 26 Jun, 2024 US10888570
Recordation of Patent Grant Mailed
Critical
12 Mar, 2024 US11925704
Patent Issue Date Used in PTA Calculation
Critical
12 Mar, 2024 US11925704
Recordation of Patent eGrant 12 Mar, 2024 US11925704
Patent eGrant Notification 12 Mar, 2024 US11925704
Mail Patent eGrant Notification 12 Mar, 2024 US11925704
Email Notification
Critical
12 Mar, 2024 US11925704
Email Notification
Critical
22 Feb, 2024 US11925704
Issue Notification Mailed
Critical
21 Feb, 2024 US11925704
Dispatch to FDC 08 Feb, 2024 US11925704
Application Is Considered Ready for Issue
Critical
08 Feb, 2024 US11925704
Issue Fee Payment Verified
Critical
30 Jan, 2024 US11925704
Response to Reasons for Allowance 30 Jan, 2024 US11925704
Issue Fee Payment Received
Critical
30 Jan, 2024 US11925704
Email Notification
Critical
09 Nov, 2023 US11925704


Cmp Dev Llc's Family Patents

Cmp Dev Llc drugs have patent protection in a total of 11 countries. It has a significant patent presence in the US with 59.5% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Cmp Dev Llc Drug List

Given below is the complete list of Cmp Dev Llc's drugs and the patents protecting them.


1. Atorvaliq

Atorvaliq is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11369567 Aqueous suspension suitable for oral administration 07 Jun, 2037
(12 years from now)
Active
US11654106 Aqueous suspension suitable for oral administration 07 Jun, 2037
(12 years from now)
Active
US11925704 Aqueous suspension suitable for oral administration 07 Jun, 2037
(12 years from now)
Active
US12168069 Aqueous suspension suitable for oral administration 07 Jun, 2037
(12 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Atorvaliq's drug page


2. Carospir

Carospir is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10493083 Spironolactone aqueous compositions 28 Oct, 2036
(11 years from now)
Active
US10624906 Spironolactone aqueous compositions 28 Oct, 2036
(11 years from now)
Active
US10660907 Spironolactone aqueous compositions 28 Oct, 2036
(11 years from now)
Active
US10888570 Spironolactone aqueous compositions 28 Oct, 2036
(11 years from now)
Active
US11389461 Spironolactone aqueous compositions 28 Oct, 2036
(11 years from now)
Active
US11395828 Spironolactone aqueous compositions 28 Oct, 2036
(11 years from now)
Active
US11491166 Spironolactone aqueous compositions 28 Oct, 2036
(11 years from now)
Active
US9757394 Spironolactone aqueous formulations 28 Oct, 2036
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Carospir's drug page


3. Liqrev

Liqrev is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11337979 Liquid oral formulations for sildenafil 24 Dec, 2038
(13 years from now)
Active
US11464778 Liquid oral formulations for sildenafil 24 Dec, 2038
(13 years from now)
Active
US11759468 Liquid oral formulations for sildenafil 24 Dec, 2038
(13 years from now)
Active
US12005062 Liquid oral formulations for sildenafil 24 Dec, 2038
(13 years from now)
Active
US12186321 Liquid oral formulations for sildenafil 24 Dec, 2038
(13 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Liqrev's drug page


4. Norliqva

Norliqva is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11253474 Pharmaceutical solution of amlodipine 24 Feb, 2041
(15 years from now)
Active
US11458095 Pharmaceutical solution of amlodipine 24 Feb, 2041
(15 years from now)
Active
US11723866 Pharmaceutical solution of amlodipine 24 Feb, 2041
(15 years from now)
Active
US12005141 Pharmaceutical solution of amlodipine 24 Feb, 2041
(15 years from now)
Active
US12226528 Pharmaceutical solution of amlodipine 24 Feb, 2041
(15 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norliqva's drug page


5. Potassium Phosphates

Potassium Phosphates is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10632150 Potassium phosphates composition for injection 19 Apr, 2039
(13 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Potassium Phosphates's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Tadliq

Tadliq is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11382917 Liquid oral formulations for tadalafil 24 Dec, 2038
(13 years from now)
Active
US11666576 Liquid oral formulations for tadalafil 24 Dec, 2038
(13 years from now)
Active
US11975006 Liquid oral formulations for tadalafil 24 Dec, 2038
(13 years from now)
Active
US12186322 Liquid oral formulations for tadalafil 24 Dec, 2038
(13 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tadliq's drug page